Drug Profile
RG 7273
Alternative Names: RG7273Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Roche
- Class Antihyperlipidaemics; Small molecules
- Mechanism of Action ATP binding cassette transporter 1 stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Dyslipidaemias
Most Recent Events
- 12 Apr 2012 Discontinued - Phase-I for Dyslipidaemias (unspecified route)
- 03 Nov 2011 RG 7273 is still in phase I trials for Dyslipidaemia
- 03 Feb 2010 Phase-I clinical trials in Dyslipidaemias (unspecified route)